More NewsRead More
SCYNEXIS, Inc. Enters Into Worldwide Agreement With Waterstone Pharmaceutical for the Development and Commercialization of SCY-635 for Viral Diseases
November 03, 2014
SCYNEXIS, Inc. Reports Second Quarter 2014 Financial Results
August 13, 2014
SCYNEXIS Provides Update on Corporate Progress and First Quarter 2014 Financial Results
June 16, 2014
SCYNEXIS, Inc. Announces Appointment Of Two Seasoned Industry Professionals To Its Board of Directors
December 03, 2014
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here